Clinical Research in Medicinal Cannabis and Cannabinoid Therapeutics


Clinical Research in Medicinal Cannabis, endocannabinoids, and Cannabinoid Therapeutics


Associate Professor Jonathan Arnold, Dr Michael Bowen, Professor Iain McGregor

Research Location

School of Psychology

Program Type



The Lambert Initiative is a research program at the University of Sydney dedicated to exploring the medicinal potential of cannabis and the cannabinoids.  We are looking to recruit up to ten new PhD students in 2017 and are offering top-up scholarships of $10,000 p.a. to APA (or equivalent) scholarship recipients who join our team based at the Brain and Mind Centre.   A wide range of chemistry, cellular, preclinical and clinical PhD projects are available for consideration that involve the development and evaluation of cannabis-based treatments for conditions such as of epilepsy, pain, sleep disorders, anxiety disorders, neurodegenerative conditions and cancer. Projects may involve areas such as patient surveys, human psychopharmacology, drug policy and clinical trials. Projects will involve supervision by the Academic and/or Associate Directors of the Lambert Initiative or their specialist collaborators. This is an exciting opportunity for ambitious and enthusiastic graduate students to contribute to a fast-paced program of research at the frontiers of medical science and pharmacology that has strong potential for major societal impact. 

Additional Information

David Allsop is an Associate Professor in the School of Psychology and Associate Director of the Clinical Research at the Lambert Initiative for Cannabinoid Therapeutics. His current work examines the impact of illicit cannabis use on various illnesses and the interaction of cannabis and illness with the healthy functioning of the endocannabinoid system. The program involves patient surveys, experimental psychopharmacology, and the efficacy of novel cannabis based drugs in a range of disease states. David is particularly interested in anxiety and mood disorders, PTSD, but also pain, epilepsy, metabolic disorders, cancer and beyond. An area of interest also includes differences in drug delivery modality and its impact on efficacy for different illnesses. In terms of cannabis as a medicine, David is also interested in whether the entourage phenomenon is real and welcomes clinical ideas to test that question.

Want to find out more?

Contact us to find out what’s involved in applying for a PhD. Domestic students and International students

Contact Research Expert to find out more about participating in this opportunity.

Browse for other opportunities within the School of Psychology .


cannabis, Cannabinoids, endocannabinoids, epilepsy, Cancer, PTSD, anxiety and mood disorders, Schizophrenia, Pain, neurodegenerative disorders, metabolic disorders, patient surveys, clinical trials, experimental psychopharmacology

Opportunity ID

The opportunity ID for this research opportunity is: 2222

Other opportunities with Associate Professor Jonathan Arnold

Other opportunities with Dr Michael Bowen

Other opportunities with Professor Iain McGregor